HWM
CVS icon

HighMark Wealth Management’s CVS Health CVS Stock Holding History

HighMark Wealth Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$97.9K Sell
1,363
-521
-28% -$40.1K 0.04% 114
2025
Q4 		$149K Sell
1,884
-33
-2% -$2.6K 0.06% 92
2025
Q3 		$145K Buy
1,917
+20
+1% +$1.37K 0.06% 94
2025
Q2 		$131K Buy
1,897
+1,380
+267% +$90.5K 0.06% 96
2025
Q1 		$35K Buy
517
+6
+1% +$359 0.02% 158
2024
Q4 		$22.9K Sell
511
-1,324
-72% -$74.3K 0.01% 187
2024
Q3 		$115K Sell
1,835
-11
-0.6% -$642 0.06% 93
2024
Q2 		$109K Sell
1,846
-186
-9% -$11.6K 0.07% 92
2024
Q1 		$162K Buy
2,032
+995
+96% +$76K 0.1% 74
2023
Q4 		$81.9K Buy
1,037
+10
+1% +$712 0.06% 102
2023
Q3 		$71.7K Buy
1,027
+108
+12% +$7.65K 0.06% 97
2023
Q2 		$63.5K Buy
919
+7
+0.8% +$498 0.05% 104
2023
Q1 		$67.7K Buy
912
+7
+0.8% +$587 0.05% 117
2022
Q4 		$84.4K Buy
905
+5
+0.6% +$482 0.06% 83
2022
Q3 		$86K Buy
900
+5
+0.6% +$495 0.07% 75
2022
Q2 		$83K Sell
895
-139
-13% -$13.6K 0.07% 76
2022
Q1 		$105K Sell
1,034
-20
-2% -$2.1K 0.07% 75
2021
Q4 		$109K Buy
1,054
+6
+0.6% +$554 0.07% 77
2021
Q3 		$89K Buy
1,048
+6
+0.6% +$503 0.07% 82
2021
Q2 		$87K Buy
1,042
+7
+0.7% +$573 0.06% 85
2021
Q1 		$78K Buy
1,035
+7
+0.7% +$510 0.06% 85
2020
Q4 		$70K Buy
1,028
+765
+291% +$49.8K 0.06% 81
2020
Q3 		$15K Buy
263
+2
+0.8% +$124 0.01% 186
2020
Q2 		$17K Buy
261
+234
+867% +$14.7K 0.02% 145
2020
Q1 		$1K Hold
27
– – ﹤0.01% 324
2019
Q4 		$2K Buy
+27
New +$1.9K ﹤0.01% 343

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

HighMark Wealth Management's CVS Position: Q1 2026 in Review

HighMark Wealth Management reduced its CVS Health (CVS) stake by 28% in Q1 2026, selling an estimated $40.1K and leaving 1,363 shares worth $97.9K. The position accounts for 0.04% of the portfolio, ranked #114.

HighMark Wealth Management first reported a position in CVS in Q4 2019 and has held it in 26 quarters since. The position peaked at $162K in Q1 2024. 1,864 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • HighMark Wealth Management held 1,363 shares of CVS Health worth $97.9K as of Q1 2026.
  • HighMark Wealth Management sold 521 CVS Health shares in Q1 2026, an estimated $40.1K.
  • CVS Health made up 0.04% of HighMark Wealth Management's portfolio in Q1 2026, its #114 holding.
  • HighMark Wealth Management first reported a position in CVS Health in Q4 2019 and has held it in 26 quarters since.
  • HighMark Wealth Management's CVS Health position peaked at $162K in Q1 2024.
  • 1,864 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on HighMark Wealth Management's 13F filing for Q1 2026, filed 6 May 2026.